Safeguard Scientifics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017 - 1994
Net Income	-14.26	27	-37.62	54.56	-15.63	Upgrade
Depreciation & Amortization	0.27	0.23	0.31	1.07	0.69	Upgrade
Share-Based Compensation	1.45	1.78	0.97	1.24	0.97	Upgrade
Other Operating Activities	9.29	-37.16	28.2	-76.84	-12.06	Upgrade
Operating Cash Flow	-3.26	-8.15	-8.14	-19.97	-26.04	Upgrade
Capital Expenditures	0	0	0	0	0	Upgrade
Acquisitions	1.21	58.11	-1.27	88.36	51.03	Upgrade
Change in Investments	-5.87	0	0	37.95	-18.93	Upgrade
Investing Cash Flow	-4.66	58.11	-1.27	126.3	32.1	Upgrade
Dividends Paid	0	0	0	-20.68	0	Upgrade
Share Issuance / Repurchase	-2.94	-40.66	0	0	0	Upgrade
Debt Issued / Paid	0	0	0	-68.57	-24.69	Upgrade
Other Financing Activities	-0.55	-0.14	-0.04	-0.24	-0.27	Upgrade
Financing Cash Flow	-3.49	-40.8	-0.04	-89.48	-24.95	Upgrade
Net Cash Flow	-11.41	9.16	-9.45	16.85	-18.88	Upgrade
Free Cash Flow	-3.26	-8.15	-8.14	-19.97	-26.03	Upgrade
Free Cash Flow Per Share	-0.20	-0.41	-0.39	-0.97	-1.27	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).